Why technology standards are critical for Quantum-Safe Security

Safeguard Insights

November 1, 2010

NuPathe Submits Zelrix NDA for the Treatment of Migraine

Safeguard Scientifics’ partner company NuPathe submitted a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA). The NDA was filed for ZelrixTM,…

Posted by James A. Datin

September 29, 2010

Safeguard Scientifics and Partner Company Avid Radiopharmaceuticals Honored with Life Sciences Awards

Today, we were honored by the Philadelphia Business Journal with the Inaugural Life Sciences Venture Impact Award, which “goes to the venture capital firm from…

Posted by James A. Datin

September 10, 2010

Advancements in Diagnostics

Advances in the life sciences will continue to have a far-reaching impact on virtually every aspect of our society. There is an abundance of companies…

Posted by James A. Datin

July 12, 2010

Bloomberg Businessweek says Avid likely to Beat GE, Bayer to Market

On the eve of the International Conference on Alzheimer’s Disease (ICAD), Bloomberg Businessweek’s Elizabeth Lopatto and Kanoko Matsuyama reported that Avid Radiopharmaceuticals, Inc., a Safeguard…

Posted by James A. Datin

July 1, 2010

The Next Frontier: Opportunities in Regenerative Medicine

While there are a wealth of opportunities to deploy capital in a variety of life sciences companies, the evolution and potential long-term impact of regenerative…

Posted by James A. Datin

June 24, 2010

New York Times puts Avid’s Technology Front and Center

Avid Radiopharmaceuticals was featured on the front page of The New York Times today. The article, “Promise Seen for Detection of Alzheimer’s,” by Gina Kolata (@ginakolata), highlights…

Posted by James A. Datin

May 21, 2010

Diagnostic Imaging Continues to Garner Investor Interest

On the heels of the BIO International Convention, I came across this piece by FierceBiotech’s Maureen Martino highlighting a panel of biotech VCs who made…

Posted by James A. Datin

January 21, 2010

Avid Radiopharmaceuticals Presents at J.P. Morgan Investor Conference

Safeguard Scientifics’ partner company Avid Radiopharmaceuticals was invited to present its technology and growth strategy at the prestigious J.P. Morgan 28th Annual Healthcare Conference in…

Posted by James A. Datin

January 12, 2010

Advanced BioHealing Profiled by Xconomy San Diego

Bruce Bigelow of Xconomy San Diego highlights Advanced BioHealing’s (ABH) commercial success with Dermagraft in his article. Bigelow details the success of Dermagraft and ABH’s…

Posted by James A. Datin